Global Active Biological Bone Market Growth (Status and Outlook) 2023-2029

Global Active Biological Bone Market Growth (Status and Outlook) 2023-2029

According to this study, the global Active Biological Bone market size will reach US$ million by 2029.

Active biological bone is a new type of bone repair material with osteoconduction and osteoinduction, which is made by compounding bone repair material with recombinant human bone morphogenetic protein (rhBMP-2) with collagen-specific binding ability. It is mainly used to fill bone defects caused by trauma or surgery that do not affect the stability of bone structure.

At present, the commonly used clinical materials for orthopedic repair mainly include autologous bone, allogeneic bone, traditional artificial bone and bioactive bone. Compared with traditional repair materials, active bio-bone can be combined with bone repair materials through recombinant signal molecules that can specifically bind to collagen to achieve highly directional repair, and the clinical efficacy is not inferior to autologous bone. It will become the best treatment for bone defects at present. implant material.

This report presents a comprehensive overview, market shares, and growth opportunities of Active Biological Bone market by product type, application, key players and key regions and countries.

Segmentation by product type:
Infuse
OP-1

Segmentation by Application:
Hospital
Clinic

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Medtronic
Stryker
Yantai Zhenghai Bio-Tech
CoreBone
Hangzhou Jiuyuan Gene Engineering

Please note: The report will take approximately 2 business days to prepare and deliver.